By InvitationNot Applicable

Mayo Clinic Precure - Prospective Study

United States100,000 participantsStarted 2026-01-19

Plain-language summary

The goal of this observational study is to 1) better understand and predict biological processes before disease begins or is identified, 2) study genomic and environmental contributors to disease, 3) identify ways to stop disease advancement before it becomes serious or complex, and 4) identify potential targets for disease therapy. Participants will be asked to: * collect biological samples, * download a mobile app, * collect speech (voice) recordings, and * complete surveys

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years * Registered Mayo Clinic patient * Able to provide informed written consent * Able to receive mail and packages within a United States (US) state * Able to collect and ship samples within a US state via FedEx for overnight delivery Exclusion Criteria: * Active hematological cancer or history of a hematological cancer * Allogeneic Bone Marrow Transplant (autologous bone marrow transplant recipients are acceptable if collected at least one month after transplant) * Other co-morbidity that, in physician's opinion, would interfere with patient's ability to participate in the study (e.g., reduced ability to comprehend, i.e., dementia, intellectual disability, etc.)

What they're measuring

Build a comprehensive, multi-omics and phenotype dataset

Timeframe: Up to 5 years

Trial details

NCT IDNCT07332598

SponsorMayo Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-12

View on ClinicalTrials.gov More Genetic Predisposition trials